
KHRNF
Healthcare · Drug Manufacturers - Specialty & Generic · $2,324 market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2022
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 29, 2022 | After the close | -0.02 | -0.02 | 0.0% |
| Aug 26, 2022 | After the close | — | -0.01 | — |
| May 2, 2022 | Before the open | — | -0.02 | — |
| Nov 22, 2021 | Before the open | — | -0.01 | — |
| Aug 23, 2021 | Before the open | 0.00 | -0.02 | — |
| Apr 29, 2021 | After the close | 0.00 | -0.03 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.03 | — |
| Nov 30, 2020 | After the close | 0.00 | -0.01 | — |
| Aug 24, 2020 | Before the open | 0.00 | -0.05 | — |
| May 28, 2020 | After the close | -0.09 | -0.08 | +11.1% |
| Mar 31, 2020 | Time not confirmed | — | -0.06 | — |
| Nov 25, 2019 | After the close | -0.08 | -0.09 | -12.5% |
| Aug 26, 2019 | Before the open | -0.09 | -0.11 | -22.2% |
Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe. It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products. The company is also involved in the operation of health centers under the Zerenia and Dr. Zerenia brand names; and provision of medical education and training programs for health professionals. It sells…
| May 30, 2019 |
| After the close |
| -0.05 |
| -0.12 |
| -140.0% |
| Mar 31, 2019 | Time not confirmed | — | -0.08 | — |
| Nov 29, 2018 | After the close | — | -0.07 | — |
| Aug 29, 2018 | After the close | — | -0.08 | — |
| May 30, 2018 | After the close | 0.00 | -0.12 | — |
| Mar 31, 2018 | Time not confirmed | 0.00 | -0.05 | — |